We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Nautilus Biotechnology Inc | NASDAQ:NAUT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.02 | 0.75% | 2.69 | 2.53 | 2.91 | 2.82 | 2.64 | 2.78 | 65,314 | 01:00:00 |
Nautilus’ management is scheduled to present on Wednesday, September 15th at 1:15 p.m. Eastern Time/10:15 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the company’s website at: https://www.nautilus.bio/investors/
About Nautilus Biotechnology, Inc.
Nautilus is a biotechnology company who is developing a proteomics platform that aims to deliver superior sensitivity more quickly, more completely, and less expensively than is currently possible. Nautilus Biotechnology aims to enable a dramatic acceleration of basic science research, significantly improve the success rate of therapeutic development, and enhance opportunities for personalized and predictive medicine. Nautilus’ corporate headquarters is in Seattle, Washington and scientific research and development is being conducted from its San Carlos, California office and labs.
Contacts
Investors:InvestorRelations@nautilus.bio
Media:Chris BlessingtonVice President, Corporate Marketing and Communicationschrisb@nautilus.bio
1 Year Nautilus Biotechnology Chart |
1 Month Nautilus Biotechnology Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions